RTC
ABBV icon

Real Talk Capital’s AbbVie ABBV Stock Holding History

Real Talk Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$545K Buy
2,167
+42
+2% +$9.04K 0.41% 49
2026
Q1 		$462K Sell
2,125
-1,118
-34% -$248K 0.44% 47
2025
Q4 		$741K Sell
3,243
-880
-21% -$200K 0.74% 31
2025
Q3 		$955K Buy
4,123
+308
+8% +$62.7K 1.03% 21
2025
Q2 		$708K Sell
3,815
-29
-0.8% -$5.39K 0.85% 27
2025
Q1 		$805K Buy
3,844
+80
+2% +$15.6K 1.09% 21
2024
Q4 		$669K Buy
+3,764
New +$692K 0.88% 32

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Real Talk Capital's ABBV Position: Q2 2026 in Review

Real Talk Capital increased its AbbVie (ABBV) stake by 2% in Q2 2026, buying an estimated $9.04K and bringing the position to 2,167 shares worth $545K. The position accounts for 0.41% of the portfolio, ranked #49.

Real Talk Capital first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $955K in Q3 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Real Talk Capital held 2,167 shares of AbbVie worth $545K as of Q2 2026.
  • Real Talk Capital bought 42 AbbVie shares in Q2 2026, an estimated $9.04K.
  • AbbVie made up 0.41% of Real Talk Capital's portfolio in Q2 2026, its #49 holding.
  • Real Talk Capital first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Real Talk Capital's AbbVie position peaked at $955K in Q3 2025.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Real Talk Capital's 13F filing for Q2 2026, filed 14 Aug 2026.